Showing results (171-180 of 191) with videos related to

Sort By:
Pageof 20
Plos One|July 19, 2012
Naturally-occurring genetic variants in human DC-SIGN increase HIV-1 capture, cell-transfer and risk of mother-to-child transmissionGeneviève Boily-Larouche, Miroslav P Milev, Lynn S Zijenah, et al.
AIDS Research and Human Retroviruses|November 17, 2016
Short Communication: Small-Molecule CD4 Mimetics Sensitize HIV-1-Infected Cells to Antibody-Dependent Cellular Cytotoxicity by Antibodies Elicited by Multiple Envelope Glycoprotein Immunogens in Nonhuman PrimatesShilei Ding, Myriam M Verly, Amy Princiotto, et al.
Viruses|August 29, 2024
Phylogenetic Network Analyses Reveal the Influence of Transmission Clustering on the Spread of HIV Drug Resistance in Quebec from 2002 to 2022Bluma G Brenner, Ruxandra-Ilinca Ibanescu, Maureen Oliveira, et al.
The Journal of Infectious Diseases|March 3, 2007
High rates of forward transmission events after acute/early HIV-1 infectionBluma G Brenner, Michel Roger, Jean-Pierre Routy, et al.
Current Issues in Molecular Biology|January 26, 2024
Excess BAFF May Impact HIV-1-Specific Antibodies and May Promote Polyclonal Responses Including Those from First-Line Marginal Zone B-Cell PopulationsKim Doyon-Laliberté, Matheus Aranguren, Josiane Chagnon-Choquet, et al.
Medicine|November 21, 2020
Impact of previous HIV resistance and virologic failures on virologic outcome following a switch to dolutegravir with 2 NRTIs among people living with HIVMohamed N'dongo Sangaré, Jean-Guy Baril, Alexandra de Pokomandy, et al.
Viruses|August 28, 2021
The Role of Phylogenetics in Unravelling Patterns of HIV Transmission towards Epidemic Control: The Quebec Experience (2002-2020)Bluma G Brenner, Ruxandra-Ilinca Ibanescu, Nathan Osman, et al.
Food Chemistry|September 5, 2020
Multi-block classification of chocolate and cocoa samples into sensory polesAlessandra Biancolillo, Sebastien Preys, Belal Gaci, et al.
Journal of Medical Virology|April 14, 2021
Comparison of saliva with oral and nasopharyngeal swabs for SARS-CoV-2 detection on various commercial and laboratory-developed assaysAnnie-Claude Labbé, Patrick Benoit, Sarah Gobeille Paré, et al.
Open Forum Infectious Diseases|November 18, 2020
Treatment Switch to Dolutegravir With 2 Nucleoside Reverse-Transcriptase Inhibitors (NRTI) in Comparison to Continuation With Protease Inhibitor/Ritonavir Among Patients With Human Immunodeficiency Virus at Risk for Prior NRTI Resistance: A Cohort Analysis of Real-World DataMohamed N'dongo Sangaré, Jean-Guy Baril, Alexandra de Pokomandy, et al.
Pageof 20